Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.29 | 5e-10 |
mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.21 | 2e-05 |
mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.18 | 2e-05 |
mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.17 | 0.0001 |
mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.17 | 0.0005 |
mRNA | PD-0332991 | CCLE | pan-cancer | AAC | 0.15 | 0.002 |
mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.17 | 0.002 |
mRNA | L-685458 | CCLE | pan-cancer | AAC | 0.11 | 0.02 |
mRNA | AEW541 | CCLE | pan-cancer | AAC | 0.11 | 0.02 |
mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.11 | 0.02 |